Ariadne Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Ariadne Wealth Management's ABBV Position: Q3 2026 in Review
Ariadne Wealth Management increased its AbbVie (ABBV) stake by 3% in Q3 2026, buying an estimated $42.3K and bringing the position to 5,730 shares worth $1.5M. The position accounts for 0.66% of the portfolio, ranked #30.
Ariadne Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Ariadne Wealth Management held 5,730 shares of AbbVie worth $1.5M as of Q3 2026.
- Ariadne Wealth Management bought 165 AbbVie shares in Q3 2026, an estimated $42.3K.
- AbbVie made up 0.66% of Ariadne Wealth Management's portfolio in Q3 2026, its #30 holding.
- Ariadne Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Ariadne Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.